Performance of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome in contaminated samples of amniotic fluid

Bruce Cohen, Jack Ludmir, Craig Towers, Juan G. Alvarez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To evaluate the reliability of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome (RDS) in the presence of common contaminants of amniotic fluid. Methods: Forty specimens of amniotic fluid collected within 72 hours of delivery were divided in five 25 µL aliquots and diluted with either phosphate-buffered saline (control), meconium, blood, vaginal fluid, or semen. The concentration of dipalmitoyl phosphatidylcholine in all five groups of samples, as measured by the dipalmitoyl phosphatidylcholine test, was compared by paired t test, Dunnett test, and analysis of variance, and correlated with the neonatal respiratory status of the newborns. Results: No significant differences in the concentration of dipalmitoyl phosphatidylcholine were found between control and the corresponding contaminated samples (P = .33). Of the 200 samples evaluated, 80 had dipalmitoyl phosphatidylcholine concentrations below 12 µg/mL and 120 had at least 12 µg/mL. Using a cutoff dipalmitoyl phosphatidylcholine concentration of 12 µg/mL, the presence of RDS was predicted accurately in all 15 control and in 61 of 65 contaminated samples. The absence of RDS, as predicted by a dipalmitoyl phosphatidylcholine value at least 12 µg/mL, was predicted accurately in 24 of 25 control samples and 96 of 100 contaminated samples. The overall accuracy of the dipalmitoyl phosphatidylcholine test in predicting RDS in contaminated samples was 98%. Conclusion: The dipalmitoyl phosphatidylcholine test is a reliable predictor of RDS in contaminated samples.

Original languageEnglish (US)
Pages (from-to)719-722
Number of pages4
JournalObstetrics and Gynecology
Volume89
Issue number5
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

1,2-Dipalmitoylphosphatidylcholine
Amniotic Fluid
Meconium
Semen
Analysis of Variance
Phosphates

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Performance of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome in contaminated samples of amniotic fluid. / Cohen, Bruce; Ludmir, Jack; Towers, Craig; Alvarez, Juan G.

In: Obstetrics and Gynecology, Vol. 89, No. 5, 01.01.1997, p. 719-722.

Research output: Contribution to journalArticle

@article{34283fa307dc44c6bf68700aaacd1c0f,
title = "Performance of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome in contaminated samples of amniotic fluid",
abstract = "Objective: To evaluate the reliability of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome (RDS) in the presence of common contaminants of amniotic fluid. Methods: Forty specimens of amniotic fluid collected within 72 hours of delivery were divided in five 25 µL aliquots and diluted with either phosphate-buffered saline (control), meconium, blood, vaginal fluid, or semen. The concentration of dipalmitoyl phosphatidylcholine in all five groups of samples, as measured by the dipalmitoyl phosphatidylcholine test, was compared by paired t test, Dunnett test, and analysis of variance, and correlated with the neonatal respiratory status of the newborns. Results: No significant differences in the concentration of dipalmitoyl phosphatidylcholine were found between control and the corresponding contaminated samples (P = .33). Of the 200 samples evaluated, 80 had dipalmitoyl phosphatidylcholine concentrations below 12 µg/mL and 120 had at least 12 µg/mL. Using a cutoff dipalmitoyl phosphatidylcholine concentration of 12 µg/mL, the presence of RDS was predicted accurately in all 15 control and in 61 of 65 contaminated samples. The absence of RDS, as predicted by a dipalmitoyl phosphatidylcholine value at least 12 µg/mL, was predicted accurately in 24 of 25 control samples and 96 of 100 contaminated samples. The overall accuracy of the dipalmitoyl phosphatidylcholine test in predicting RDS in contaminated samples was 98{\%}. Conclusion: The dipalmitoyl phosphatidylcholine test is a reliable predictor of RDS in contaminated samples.",
author = "Bruce Cohen and Jack Ludmir and Craig Towers and Alvarez, {Juan G.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1016/S0029-7844(97)00092-6",
language = "English (US)",
volume = "89",
pages = "719--722",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Performance of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome in contaminated samples of amniotic fluid

AU - Cohen, Bruce

AU - Ludmir, Jack

AU - Towers, Craig

AU - Alvarez, Juan G.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Objective: To evaluate the reliability of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome (RDS) in the presence of common contaminants of amniotic fluid. Methods: Forty specimens of amniotic fluid collected within 72 hours of delivery were divided in five 25 µL aliquots and diluted with either phosphate-buffered saline (control), meconium, blood, vaginal fluid, or semen. The concentration of dipalmitoyl phosphatidylcholine in all five groups of samples, as measured by the dipalmitoyl phosphatidylcholine test, was compared by paired t test, Dunnett test, and analysis of variance, and correlated with the neonatal respiratory status of the newborns. Results: No significant differences in the concentration of dipalmitoyl phosphatidylcholine were found between control and the corresponding contaminated samples (P = .33). Of the 200 samples evaluated, 80 had dipalmitoyl phosphatidylcholine concentrations below 12 µg/mL and 120 had at least 12 µg/mL. Using a cutoff dipalmitoyl phosphatidylcholine concentration of 12 µg/mL, the presence of RDS was predicted accurately in all 15 control and in 61 of 65 contaminated samples. The absence of RDS, as predicted by a dipalmitoyl phosphatidylcholine value at least 12 µg/mL, was predicted accurately in 24 of 25 control samples and 96 of 100 contaminated samples. The overall accuracy of the dipalmitoyl phosphatidylcholine test in predicting RDS in contaminated samples was 98%. Conclusion: The dipalmitoyl phosphatidylcholine test is a reliable predictor of RDS in contaminated samples.

AB - Objective: To evaluate the reliability of the dipalmitoyl phosphatidylcholine test in predicting respiratory distress syndrome (RDS) in the presence of common contaminants of amniotic fluid. Methods: Forty specimens of amniotic fluid collected within 72 hours of delivery were divided in five 25 µL aliquots and diluted with either phosphate-buffered saline (control), meconium, blood, vaginal fluid, or semen. The concentration of dipalmitoyl phosphatidylcholine in all five groups of samples, as measured by the dipalmitoyl phosphatidylcholine test, was compared by paired t test, Dunnett test, and analysis of variance, and correlated with the neonatal respiratory status of the newborns. Results: No significant differences in the concentration of dipalmitoyl phosphatidylcholine were found between control and the corresponding contaminated samples (P = .33). Of the 200 samples evaluated, 80 had dipalmitoyl phosphatidylcholine concentrations below 12 µg/mL and 120 had at least 12 µg/mL. Using a cutoff dipalmitoyl phosphatidylcholine concentration of 12 µg/mL, the presence of RDS was predicted accurately in all 15 control and in 61 of 65 contaminated samples. The absence of RDS, as predicted by a dipalmitoyl phosphatidylcholine value at least 12 µg/mL, was predicted accurately in 24 of 25 control samples and 96 of 100 contaminated samples. The overall accuracy of the dipalmitoyl phosphatidylcholine test in predicting RDS in contaminated samples was 98%. Conclusion: The dipalmitoyl phosphatidylcholine test is a reliable predictor of RDS in contaminated samples.

UR - http://www.scopus.com/inward/record.url?scp=0030895221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030895221&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(97)00092-6

DO - 10.1016/S0029-7844(97)00092-6

M3 - Article

VL - 89

SP - 719

EP - 722

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -